Phase III study of Ninlaro in systemic AL amyloidosis misses first of two primary endpoints June 6, 2019
Asclepius initiates phase I/II study of BCMA CAR-NK cells in relapsed/refractory multiple myeloma June 6, 2019
Phase III ELEVATE-TN trial of Calquence in previously untreated CLL meets primary endpoint June 6, 2019
New gene variants found to protect against osteoporosis in patients with Gaucher's disease June 6, 2019
RSS